HUM241018C247500
- 13.37
- +1.23+10.13%
Humana Newsroom
Humana Is Maintained at Hold by Truist Securities
Oppenheimer Maintains Humana(HUM.US) With Buy Rating, Maintains Target Price $280
Truist Financial Maintains Humana(HUM.US) With Hold Rating, Cuts Target Price to $260
Humana (HUM) Receives a Rating Update From a Top Analyst
Humana Is Maintained at Equal-Weight by Barclays
Humana Analyst Ratings
CVS Health Upgraded at Barclays on Medicare Prospects
JPMorgan Adjusts Price Target on Humana to $254 From $396, Maintains Neutral Rating
Barclays Maintains Humana(HUM.US) With Hold Rating, Cuts Target Price to $250
Stephens & Co. Reiterates Equal-Weight on Humana, Maintains $250 Price Target
Humana Raised to Outperform From Market Perform by Bernstein
Humana Ends Selloff as Bernstein Upgrades on Attractive Entry Point
Humana Is Maintained at Outperform by RBC Capital
Humana Analyst Ratings
RBC Capital Maintains Humana(HUM.US) With Buy Rating, Cuts Target Price to $265
RBC Cuts Price Target on Humana to $265 From $400, Keeps Outperform Rating
RBC Capital Reaffirms Their Buy Rating on Humana (HUM)
Cognizant's Revenue Outlook: A Hold Rating Amidst Humana's Anticipated Spending Changes
Bernstein Upgrades Humana(HUM.US) to Buy Rating, Cuts Target Price to $308
Bernstein lowers Humana's target price to $308.